Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA gyrase A is one of the two essential subunits (GyrA and GyrB) that make up DNA gyrase, a specialized type II topoisomerase found in bacteria. This enzyme is unique for its ability to introduce negative supercoils into closed circular double-stranded DNA in an ATP-dependent manner, a function critical for maintaining proper DNA topology during replication and transcription. The functional enzyme is a heterotetramer composed of two GyrA and two GyrB subunits (A₂B₂ complex). GyrA is responsible for binding and encapsulating DNA and contains the active site tyrosine. DNA gyrase maintains appropriate levels of chromosomal supercoiling required for vital processes. It is an attractive target for antibacterial agents.
Inhibition of DNA gyrase activity, stabilization of cleavage complexes
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Gyrase A (GyrA).